3892 Transhydrogeanse domain II
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Hydrocarbons | 1 | 0.0 | 48× | not tested | |
| Lipids and lipid-like molecules | 2 | 0.3 | 6.07× | not tested | |
| Benzenoids | 1 | 0.2 | 4.62× | not tested | |
| Nucleosides, nucleotides, and analogues | 2 | 0.8 | 2.45× | not tested | |
| Homogeneous metal compounds | 2 | 1.5 | 1.38× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03461 | NAP | Nicotinamide adenine dinucleotide phosphate | 4 |
| DB09092 | — | — | 2 |
| DB00157 | — | NADH | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 10 |
| D12 | DODECANE | 4 |
| NAP | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 4 |
| BEN | BENZAMIDINE | 2 |
| HGmetal | MERCURY (II) ION | 2 |
| PKZ | Palmitoyl-CoA | 2 |
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 1 |